Patents by Inventor Marilynn VETZEL

Marilynn VETZEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20220265841
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: May 5, 2022
    Publication date: August 25, 2022
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20210154311
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: February 2, 2021
    Publication date: May 27, 2021
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20210154312
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: February 2, 2021
    Publication date: May 27, 2021
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • Conjugates for treating diseases caused by PSMA expressing cells
    Patent number: 10912840
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: February 9, 2021
    Assignee: ENDOCYTE, INC.
    Inventors: Iontcho Radoslavov Vlahov, Joseph Anand Reddy, Alicia Bloomfield, Ryan Dorton, Melissa Nelson, Marilynn Vetzel, Christopher Paul Leamon
  • CCK2R-drug conjugates
    Patent number: 10500286
    Abstract: The disclosure provided herein pertains to CCK2R-drug conjugates. In particular, the disclosure pertains to CCK2R-drug conjugates that target the delivery of drugs to a mammalian recipient. Also described are methods of making and using CCK2R-drug conjugates.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: December 10, 2019
    Assignee: Endocyte, Inc.
    Inventors: Garth L. Parham, Melissa Nelson, Marilynn Vetzel, Christina M. Dircksen, Joseph Anand Reddy, Christopher Paul Leamon, Iontcho Radoslavov Vlahov
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20190314515
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: May 28, 2019
    Publication date: October 17, 2019
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20180289826
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: May 25, 2018
    Publication date: October 11, 2018
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20180271991
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: June 4, 2018
    Publication date: September 27, 2018
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20180256734
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: May 11, 2018
    Publication date: September 13, 2018
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa Nelson, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20180256736
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: May 11, 2018
    Publication date: September 13, 2018
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20180256737
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: May 11, 2018
    Publication date: September 13, 2018
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa Nelson, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20180256733
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: May 11, 2018
    Publication date: September 13, 2018
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20180256735
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: May 11, 2018
    Publication date: September 13, 2018
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa Nelson, Marilynn VETZEL, Christopher Paul LEAMON
  • CCK2R-DRUG CONJUGATES
    Publication number: 20180228909
    Abstract: The disclosure provided herein pertains to CCK2R-drug conjugates. In particular, the disclosure pertains to CCK2R-drug conjugates that target the delivery of drugs to a mammalian recipient. Also described are methods of making and using CCK2R-drug conjugates.
    Type: Application
    Filed: August 10, 2016
    Publication date: August 16, 2018
    Inventors: Garth L. PARHAM, Melissa NELSON, Marilynn VETZEL, Christina M. DIRCKSEN, Joseph Anand REDDY, Christopher Paul LEAMON, Iontcho Radoslavov VLAHOV
  • Conjugates for treating diseases caused by PSMA expressing cells
    Patent number: 9782493
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: October 10, 2017
    Assignee: ENDOCYTE, INC.
    Inventors: Iontcho Radoslavov Vlahov, Joseph Anand Reddy, Alicia Bloomfield, Ryan Dorton, Melissa Nelson, Marilynn Vetzel, Christopher Paul Leamon
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20170258932
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: May 26, 2017
    Publication date: September 14, 2017
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • Conjugates for treating diseases caused by PSMA expressing cells
    Patent number: 9636413
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: May 2, 2017
    Assignee: ENDOCYTE, INC.
    Inventors: Iontcho Radoslavov Vlahov, Joseph Anand Reddy, Alicia Bloomfield, Ryan Dorton, Melissa Nelson, Marilynn Vetzel, Christopher Paul Leamon
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20160361433
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: August 24, 2016
    Publication date: December 15, 2016
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20160361432
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: August 24, 2016
    Publication date: December 15, 2016
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON
  • CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
    Publication number: 20160361376
    Abstract: The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
    Type: Application
    Filed: August 24, 2016
    Publication date: December 15, 2016
    Inventors: Iontcho Radoslavov VLAHOV, Joseph Anand REDDY, Alicia BLOOMFIELD, Ryan DORTON, Melissa NELSON, Marilynn VETZEL, Christopher Paul LEAMON